Stanford Shatters Record for Study Start-up For NIH COVID-19 Study Investigating Remdesivir

Stanford University moved quickly to ramp up the Gilead remdesivir global clinical trial—and enrolled 30 participants quickly thereafter for the adaptive clinical trial. And the elite San Francisco Bay Area academic medical center recently began enrolling patients in...

Elite Research Centers Ink Deal with Lonza to Evaluate (Pilot) Cell Therapy Manufacturing for Next Generation Treatments

In a notable partnership, Switzerland-based Lonza inked a partnership with leading research institutes and academic medical centers including Stanford University School of Medicine, Fred Hutchinson Cancer Research Center and Parker Institute for Cancer Immunotherapy...

Pin It on Pinterest